
France lashes out as EU agrees to tariff pact with Washington
The framework agreement, announced Sunday between two economies representing nearly a third of global trade, allows the U.S. to impose a 15% import tariff on most EU goods starting next month. The deal offers limited protection for key sectors, including the automotive and pharmaceutical industries.
While the 15% rate is half of what Washington initially threatened, it still exceeds European expectations significantly.
U.S. President Donald Trump, who has sought to reshape global trade using tariff leverage since returning to the White House earlier this year, praised the accord during a visit to Scotland, calling it 'the biggest deal ever made.'
But France, the EU's second-largest economy, was outspoken in its disapproval.
'It is a dark day when an alliance of free peoples, brought together to affirm their common values and to defend their common interests, resigns itself to submission,' French Prime Minister Francois Bayrou wrote on X (formerly Twitter).
French President Emmanuel Macron has made no public statement on the matter.
While the mood across Europe was subdued, most governments agreed that failing to reach an agreement would have triggered a far worse scenario.
'This agreement has succeeded in averting a trade conflict that would have hit the export-oriented German economy hard,' said German Chancellor Friedrich Merz, whose country leads the EU bloc's economic rankings.
EU Trade Commissioner Maros Sefcovic said during a press conference that allowing 30% tariffs to be imposed would have been 'much, much worse.'
'This is clearly the best deal we could get under very difficult circumstances,' he added.
Some member states acknowledged the deal provides stability following months of trade tensions with the U.S. Sweden described it as the 'least bad alternative,' while Spain supported it 'without enthusiasm.'
A final deal will likely require ratification from EU capitals.
Still work to do
Because trade policy falls under the European Commission's authority, French objections are unlikely to derail the framework agreement. However, the deal has not yet been finalised.
Many of the agreement's specifics remain unknown. EU officials said they expect clarification in a joint statement to be released by August 1. Additional negotiations will follow to turn the agreement into a full-fledged deal.
Germany also called for further negotiations, particularly regarding the steel sector.
President Trump said the deal—alongside an investment package that exceeds the Japan agreement signed last week—would strengthen trans-Atlantic relations after years of what he described as unfair treatment of U.S. exporters.
Japan's package will include up to $550 billion in equity, loans and guarantees from state-run agencies, to be invested at Trump's discretion, according to Tokyo. In contrast, EU officials stated that the EU's $600 billion investment figure is based on non-binding intentions from the private sector.
The agreement is expected to bring regulatory clarity to European industries, including those in the automotive, aerospace, and chemical sectors. However, EU negotiators had originally pushed for a zero-for-zero tariff deal. A 15% tariff remains significantly higher than the U.S.'s average import tariff rate of 2.5% before Trump's return.
More clarity, but a challenge
European stocks opened higher on Monday, with the STOXX 600 reaching a four-month high. Tech and healthcare sectors led the gains.
'The 15% rate is better than the market was fearing,' said Jefferies economist Mohit Kumar.
Still, many European businesses remain conflicted about the outcome.
'Those who expect a hurricane are grateful for a storm,' said Wolfgang Große Entrup, head of the German Chemical Industry Association (VCI). 'Further escalation has been avoided. Nevertheless, the price is high for both sides. European exports are losing competitiveness. U.S. customers are paying the tariffs.'
A major concern remains how the EU's promise to invest hundreds of billions of dollars in the U.S. and sharply increase energy imports can be realized.
It remains unclear whether specific investment pledges have been made, or if the details are still being finalized.
While the EU has committed to $750 billion in strategic purchases over the next three years—including oil, liquefied natural gas (LNG), and nuclear fuel—the U.S. may struggle to meet the demand.
Though U.S. LNG production capacity is expected to nearly double over the next four years, analysts say it still won't be enough to meet Europe's needs. Oil production forecasts have also been revised downward.
Despite the uncertainties, analysts say the deal has reduced market instability. Oil prices edged up on Monday.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


France 24
8 minutes ago
- France 24
French health experts speak out against bee-killing pesticide
The legislation to reintroduce in France acetamiprid, a pesticide that is harmful to ecosystems but popular with many farmers in Europe, was adopted on July 8, but without a proper debate to bypass gridlock in a divided parliament. The move sparked anger in France, and support for a student-initiated petition against the legislation has snowballed, with university lecturers, left-wing lawmakers and star chefs backing it. The petition had garnered more than 2 million signatures by Tuesday. Health experts and patient associations have now weighed in, saying in an open letter in French daily Le Monde that they cannot back "a law that is dangerous to the health of our fellow citizens". President Emmanuel Macron, who has been under increasing pressure to act, said he is waiting to hear the verdict of the Constitutional Council, which is expected to rule on the constitutionality of the law on August 7. The health experts and patient associations urged the Constitutional Council to reject the legislation, calling on its members to "respond to the democratic demand strongly expressed by French citizens". The signatories included Agnes Linglart, president of the French Paediatric Society, Olivier Coutard, president of the scientific council of France's flagship scientific research centre CNRS and Gerard Socie, president of the scientific council of the National Cancer Institute. The Constitutional Council, the letter said, must protect future generations from the legislation that "without a shadow of reasonable doubt compromises the health of young people, children and the unborn". The letter said the Senate committee preparing the bill heard from agricultural unions and government agencies but not "doctors, toxicologists or epidemiologists". The senators did not consult representatives of the CNRS, health and labour ministries, even though occupational exposure to pesticides is a risk factor for humans, the letter said. Citing the INSERM health and medical research organisation, the letter pointed to evidence of a link between exposure to pesticides and the occurrence of cancers, neurodegenerative, pulmonary and hormone-related disorders. Banned in France since 2018, the chemical remains legal in the European Union.


France 24
8 minutes ago
- France 24
European pharma industry still worried about tariffs
The agreement sets a 15 percent tariff on most EU goods imported into the United States, but Washington could still take steps that would see medicines face a higher levy. The EFPIA trade association for the European pharmaceutical industry said it was monitoring announcements on the details of the deal "as key implications for the pharmaceutical sector remain uncertain". An EU fact sheet on the trade deal said the 15 percent rate ceiling would also apply to any potential future tariffs on pharmaceuticals, including Section 232 tariffs meant to protect US national security. Most EU pharmaceuticals currently enter the United States without a tariff, and the EU said this would remain the case until the US decides on whether to impose additional tariffs based on Section 232. Earlier this month Trump threatened tariffs of up to 200 percent on pharmaceuticals in as soon as one year if foreign firms did not begin to manufacture more in the United States. In the spring, in the face of these risks, large European pharmaceutical groups including Roche, Novartis and Sanofi announced more than $200 billion of additional investments in the United States, the world's largest drug market. But US pharmaceutical firms have also set up shop in Ireland, attracted by its low corporate tax rate. The sector employs about 50,000 people and accounted for nearly half of Irish exports last year, reaching 100 billion euros ($116 billion). The EFPIA criticised tariffs as a policy instrument. "Tariffs on medicines are a blunt instrument that will disrupt supply chains, impact on investment in research and development, and ultimately harm patient access to medicines on both sides of the Atlantic," it said.


Euronews
37 minutes ago
- Euronews
Exclusive: Cross-party MEPs call for EU sanctions on Israel over Gaza
A group of 40 cross-party MEPs are pressing on the European Union to suspend its trade deal with Israel and impose sanctions on the Netanyahu-led government, as an UN-backed body warns of signs of famine and widespread starvation in the Gaza Strip. In a joint statement seen exclusively by Euronews, the lawmakers call on the EU to hold the Israeli government accountable for actions that 'blatantly breach the Geneva Convention and international humanitarian law.' The statement also urges Hamas to immediately release Israeli hostages still held captive in Gaza after they were kidnapped from Israel during October 7 2023 attacks. 'Future generations will judge today's leaders on their response, or lack thereof, to the atrocities in Gaza. Failing to act now will be remembered as a moral stain on humanity,' the statement reads. 'The time for moral cowardice is over, and action must be swift.' The coalition of MEPs explicitly call for sanctions on the Israeli government, a move the EU has so far avoided despite allies including the United Kingdom and Norway moving to sanction two Israeli ministers considered extremist, Itamar Ben-Gvir and Bezalel Smotrich. On Tuesday, the Netherlands imposed travel bans on both ministers in response to the deepening crisis in Gaza. The 40 signatories also press on the Commission to suspend the EU's Association Agreement with Israel, which defines the trading and political relations between both sides, and which has often been touted as the best tool at the EU's disposal to pressure Israel into improving a spiralling humanitarian situation in the Gaza Strip. A previous review by the EU's diplomatic arm found indications Israel had breached the human rights obligations enshrined in its Association Agreement with the bloc, but the process failed to trigger any concrete reprisals beyond a discussion between the EU's top diplomat Kaja Kallas and her Israeli counterpart, foreign minister Gideon Sa'ar. Those talks resulted in an 'agreement' by Israel to scale up the humanitarian assistance reaching Gaza. But concerns about the humanitarian situation on-the-ground have mounted since. On Monday, the European Commission tabled the partial suspension of Israel's access to the EU's Horizon Europe research and innovation programme in response to its actions in Gaza. But the signatories of the statement call for a much more stringent response, warning "mere words of condemnation are inadequate." They represent 14 of the EU's 27 countries and six different political groups, from The Left to the centre-right European People's Party (EPP). Israel's war against Hamas in Gaza has exposed deep political and national fault-lines in the European Union. But the deepening humanitarian crisis is prompting lawmakers from ideologically opposed groups to join forces in calling for more decisive EU action. 'MEPs from across the spectrum of pro-European, pro-democratic parties have united behind this statement,' MEP Evin Incir, who sits on the centre-left Socialists and Democrats (S&D) group, told Euronews, adding that more signatories were expected to support the statement in the coming hours. 'Our concerns are directed at both the European Commission and EU member states, who all need to be more decisive in their response to the unfolding humanitarian crisis,' she added. The statement comes as the Integrated Food Security Phase Classification (IPC), a global watchdog monitoring hunger with the backing of governments and the UN, said there is 'mounting evidence' that 'widespread starvation, malnutrition, and disease are driving a rise in hunger-related deaths' in the besieged territory. Israeli government officials have either denied that there is famine in Gaza or deflected the blame. There have been multiple reports of armed gangs looting aid deliveries and selling the contents on the black market, which could be exacerbating the crisis.